FTC wins $448 million disgorgement from AbbVie and Besins
AbbVie has said it will appeal its loss against the Federal Trade Commission in a lawsuit for monopolising Androgel through sham litigation, as a Pennsylvania federal court ordered the drugmaker and Besins Healthcare to pay $448 million to consumers.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10